Cargando…
Transfection‐induced Tumor Necrosis Factor‐α Increases the Susceptibility of Human Glioma Cells to Lysis by Lymphokine‐activated Killer Cells: Continuous Expression of Intercellular Adhesion Molecule‐1 on the Glioma Cells
To develop more effective adoptive immunotherapy, we transfected the human tumor necrosis factor‐α (TNF‐α) gene into human glioma cells (U251‐SP), which were used as target cells. TNF‐α is known to increase both the expression of intercellular adhesion molecule‐1 (ICAM‐1) on the surface of glioma ce...
Autores principales: | Takaoka, Toru, Yoshida, Jun, Mizuno, Masaaki, Sugita, Kenichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919548/ https://www.ncbi.nlm.nih.gov/pubmed/7915264 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02424.x |
Ejemplares similares
-
Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene
por: Mizuno, Masaaki, et al.
Publicado: (1995) -
Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
por: Böhm, M., et al.
Publicado: (1994) -
Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
por: Schellhorn, Melina, et al.
Publicado: (2015) -
The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid
por: Alexander, C L, et al.
Publicado: (1999) -
T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma
por: Quan, Chuntao, et al.
Publicado: (2017)